Lo Bello F, Ieni A, Hansbro PM, Ruggeri P, Di Stefano A, Nucera F, Coppolino I, Monaco F, Tuccari G, Adcock IM, et al
[SELECT trial] Metabolic dysfunction-associated steatohepatitis (MASH) (adults) For the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults
Well-Characterized Pharmacology Liraglutide has been extensively studied, resulting in a large body of scientific literature supporting ongoing research applications
Glutathione conjugation protects against AQ-induced toxicity and GSTP1 is able to conjugate its quinoneimine metabolites AQ-QI and DEA-QI with glutathione
Adems, L-carnitina tartrato de Carnipure est aprobada en Japn, Corea y China como seguro para uso oral